The Association Between Ferroptosis and Neurodegenerative Diseases and Its Regulatory Mechanisms

Authors

  • Jingwen Wang Department of Biotechnology, Drake Joint College of Qingdao University, Qingdao 266071, China

DOI:

https://doi.org/10.54097/g3rtvj10

Keywords:

Ferroptosis; Neurodegenerative diseases; Molecular mechanism.

Abstract

Neurodegenerative diseases (NDDs) are characterized by specific damage to neurons in certain brain regions, and their pathogenesis is complex with the lack of effective early intervention methods. Ferroptosis is a novel iron-dependent form of cell death driven by lipid peroxidation. In recent years, it has been demonstrated to play an important role in the pathogenesis of NDDs. Multiple iron metabolism and lipid oxidation pathways are closely associated with classic pathological damage in the brain. This article systematically reviews the molecular mechanism of ferroptosis, combines three common diseases: Alzheimer's disease, Parkinson's disease, and Huntington's disease, to analyze their pathogenesis and the role of ferroptosis in it. At the same time, it summarizes the experimental results of various intervention methods targeting ferroptosis at the present stage, objectively summarizes the existing research shortcomings and transformation dilemmas in this field, which can provide theoretical references and new ideas for the mechanism analysis of NDDs and the development of targeted new drugs.

Downloads

Download data is not yet available.

References

[1] Lu G, Pan J S, Li J X. Mechanisms and therapeutic potential of programmed cell death in neurodegenerative diseases[J]. Scientia Sinica Vitae, 2026, 56(4): 828-842. (Chinese) DOI: https://doi.org/10.1360/SSV-2025-0282

[2] Wang C Y, Liu X L, Sun Y, et al. Ferroptosis and its research progress in neurodegenerative diseases[J]. Acta Universitatis Medicinalis Anhui, 2023, 58(10): 1801.

[3] Dixon S J, Lemberg K M, Lamprecht M R, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5): 1060-1072. DOI: https://doi.org/10.1016/j.cell.2012.03.042

[4] Costa I, Barbosa D J, Benfeito S, et al. Molecular mechanisms of ferroptosis and their involvement in brain diseases[J]. Pharmacology & Therapeutics, 2023, 244: 108373. DOI: https://doi.org/10.1016/j.pharmthera.2023.108373

[5] Fujii J, Imai H. Oxidative metabolism as a cause of lipid peroxidation in the execution of ferroptosis[J]. International Journal of Molecular Sciences, 2024, 25(14): 7544. DOI: https://doi.org/10.3390/ijms25147544

[6] Pope L E, Dixon S J. Regulation of ferroptosis by lipid metabolism[J]. Trends in Cell Biology, 2023, 33(12): 1077-1087. DOI: https://doi.org/10.1016/j.tcb.2023.05.003

[7] Wang F, Wang J, Shen Y, et al. Iron dyshomeostasis and ferroptosis: a new Alzheimer's disease hypothesis?[J]. Frontiers in Aging Neuroscience, 2022, 14: 830569. DOI: https://doi.org/10.3389/fnagi.2022.830569

[8] Bi M, Du X, Jiao Q, et al. α-Synuclein regulates iron homeostasis via preventing Parkin-mediated DMT1 ubiquitylation in Parkinson's disease models[J]. ACS Chemical Neuroscience, 2020, 11(11): 1682-1691. DOI: https://doi.org/10.1021/acschemneuro.0c00196

[9] Chen Y, Luo X, Yin Y, et al. The interplay of iron, oxidative stress, and α-synuclein in Parkinson's disease progression[J]. Molecular Medicine, 2025, 31(1): 154. DOI: https://doi.org/10.1186/s10020-025-01208-3

[10] Skouta R, Dixon S J, Wang J, et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models[J]. Journal of the American Chemical Society, 2014, 136(12): 4551-4556. DOI: https://doi.org/10.1021/ja411006a

[11] Túnez I, Sánchez-López F, Agüera E, et al. Important role of oxidative stress biomarkers in Huntington's disease[J]. Journal of Medicinal Chemistry, 2011, 54(15): 5602-5606. DOI: https://doi.org/10.1021/jm200605a

[12] Entezari S, Haghi S M, Norouzkhani N, et al. Iron chelators in treatment of iron overload[J]. Journal of Toxicology, 2022, 2022: 4911205. DOI: https://doi.org/10.1155/2022/4911205

[13] Wang J, Fu J, Zhao Y, et al. Iron and targeted iron therapy in Alzheimer's disease[J]. International Journal of Molecular Sciences, 2023, 24(22): 16353. DOI: https://doi.org/10.3390/ijms242216353

[14] Kagan V E, Mao G, Qu F, et al. Oxidized arachidonic and adrenic phosphatidylethanolamines navigate cells to ferroptosis[J]. Nature Chemical Biology, 2017, 13(1): 81-90. DOI: https://doi.org/10.1038/nchembio.2238

Downloads

Published

15-11-2026

Issue

Section

Articles

How to Cite

Wang , J. (2026). The Association Between Ferroptosis and Neurodegenerative Diseases and Its Regulatory Mechanisms. International Journal of Biology and Life Sciences, 17(2), 58-62. https://doi.org/10.54097/g3rtvj10